Fundz

Electra Therapeutics Promotes Chris Clark to Chief Financial Officer

PUBLIC · ETRASep 09, 2026
Internal move“the promotion of Chris Clark, CFA, to Chief Financial Officer. Mr. Clark joined Electra in December 2025 as Executive Vice President, Strategy and Finance”

Position

Chief Financial Officer

Company

Electra Therapeutics

Chris Clark
South San FranciscoManufacturingBiotechnologySustainabilityHealth CareScience And EngineeringMining

Description

Electra Therapeutics has announced the promotion of Chris Clark, CFA, to Chief Financial Officer. Mr. Clark joined the company in December 2025 and has over two decades of life sciences investment experience.

Quick answer

Electra Therapeutics Promotes Chris Clark to Chief Financial Officer (September 9, 2026). Electra Therapeutics is based in South San Francisco, California, United States.

Who is the new Chief Financial Officer at Electra Therapeutics?
Electra Therapeutics named Chris Clark Chief Financial Officer, announced September 9, 2026.
What did Electra Therapeutics announce on September 9, 2026?
Electra Therapeutics has announced the promotion of Chris Clark, CFA, to Chief Financial Officer. Mr. Clark joined the company in December 2025 and has over two decades of life sciences investment experience.
What does Electra Therapeutics do?
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
Where is Electra Therapeutics based?
Electra Therapeutics is based in South San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
The Hain Celestial Group (October 15, 2026), Aurora Cannabis (September 9, 2026), Zimmer (September 8, 2026) and STAAR Surgical (September 8, 2026) also announced leadership changes within 45 days of Electra Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Sustainability and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Electra Therapeutics, and when

A new leader at Electra Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Electra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Electra Therapeutics

Location

230 East Grand Avenue, Suite S-100

South San Francisco, California, United States

About

Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Electra Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kathy
Likely contact at this company
••••••••@••••••••

See Kathy's verified email →

Kellyn
Likely contact at this company
••••••••@••••••••

See Kellyn's verified email →

Steve
Likely contact at this company
••••••••@••••••••

See Steve's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Electra Therapeutics's next move

Learn about Strategic plan

Electra Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.